{"id":24200,"date":"2023-09-15T09:00:22","date_gmt":"2023-09-15T07:00:22","guid":{"rendered":"https:\/\/idibell.cat\/?p=24200"},"modified":"2023-09-15T10:05:28","modified_gmt":"2023-09-15T08:05:28","slug":"un-de-cada-tres-homes-a-tot-el-mon-esta-infectat-amb-el-virus-del-papilloma-huma-genital","status":"publish","type":"post","link":"https:\/\/idibell.cat\/2023\/09\/un-de-cada-tres-homes-a-tot-el-mon-esta-infectat-amb-el-virus-del-papilloma-huma-genital\/","title":{"rendered":"Un de cada tres homes a tot el m\u00f3n est\u00e0 infectat amb el virus del papil\u00b7loma hum\u00e0 genital"},"content":{"rendered":"<p>Un estudi liderat pel grup de recerca en Infeccions i C\u00e0ncer de l&#8217;Institut d&#8217;Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) i l&#8217;Institut Catal\u00e0 d&#8217;Oncologia (ICO), en el que tamb\u00e9 hi ha participat l&#8217;Organitzaci\u00f3 Mundial de la Salut (OMS), mostra que gaireb\u00e9 <strong>1 de cada 3 homes de 15 anys o m\u00e9s est\u00e0 infectat amb almenys un tipus de virus del papil\u00b7loma hum\u00e0 genital (VPH)<\/strong> i 1 de cada 5 est\u00e0 infectat amb un o m\u00e9s dels que s\u00f3n coneguts com d&#8217;alt risc o oncog\u00e8nics. Aquestes estimacions mostren que els homes sovint presenten infeccions genitals per VPH i emfatitzen la import\u00e0ncia d&#8217;incorporar-los en les estrat\u00e8gies \u00a0per controlar la infecci\u00f3 per VPH i reduir la incid\u00e8ncia de malalties relacionades en els homes i tamb\u00e9 en les dones.<\/p>\n<p>L&#8217;estudi, publicat a la revista <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2214109X23003054\"><em>The Lancet Global Health<\/em><\/a>, amb una revisi\u00f3 sistem\u00e0tica i un meta-an\u00e0lisis ha avaluat la prevalen\u00e7a de la infecci\u00f3 genital per VPH en la poblaci\u00f3 masculina general a partir d&#8217;estudis publicats entre gener de 1995 i juny de 2022. <strong>La prevalen\u00e7a global \u00e9s del 31% per a qualsevol tipus de VPH<\/strong> i del 21% pels\u00a0 VPH d&#8217;alt risc. El VPH-16 \u00e9s el genotip m\u00e9s prevalent (5%) seguit del VPH-6 (4%). La prevalen\u00e7a del virus \u00e9s m\u00e9s alta en adults joves, amb un pic entre els 25 i els 29 anys que s&#8217;estabilitza o disminueix lleugerament despr\u00e9s.<\/p>\n<p>La majoria de les infeccions per VPH en homes i dones s\u00f3n asimptom\u00e0tiques i transit\u00f2ries, per\u00f2 en alguns casos quan el sistema immunitari no pot eliminar la infecci\u00f3, aquesta pot provocar c\u00e0ncer. Cada any al m\u00f3n, m\u00e9s de 340.000 dones moren de c\u00e0ncer de coll uter\u00ed, del qual el VPH n\u2019\u00e9s causa necess\u00e0ria. En els homes, la infecci\u00f3 pel VPH tendeix a manifestar-se a trav\u00e9s de berrugues anogenitals, que poden causar morbiditat i augmenten les taxes de transmissi\u00f3 del VPH. El 90% de les berrugues anogenitals estan causades pels VPH-6 i VPH-11. Les infeccions per VPH tamb\u00e9 s&#8217;associen amb c\u00e0ncers de penis, anal i d&#8217;orofaringe, que solen estar relacionats amb el VPH-16. L&#8217;Ag\u00e8ncia Internacional per a la Recerca del C\u00e0ncer va estimar que hi va haver uns <strong>69.400 casos de c\u00e0ncer en homes causats pel VPH el 2018<\/strong>.<\/p>\n<p>&#8220;<em>Aquest estudi global sobre la prevalen\u00e7a de la infecci\u00f3 genital per VPH entre els homes suggereix que la prevalen\u00e7a \u00e9s alta i que continua sent alta al llarg de tota la vida sexual. \u00c9s important incorporar els homes en les estrat\u00e8gies de prevenci\u00f3 del VPH per reduir la morbiditat i mortalitat relacionada amb aquest virus en homes i, finalment, aconseguir l&#8217;eliminaci\u00f3 del c\u00e0ncer de coll uter\u00ed i altres malalties relacionades<\/em>&#8220;, explica la <strong>Dra. Laia Bruni<\/strong>, investigadora principal de l&#8217;IDIBELL i l&#8217;Institut Catal\u00e0 d&#8217;Oncologia, i l\u00edder del projecte.<\/p>\n<p>Text adaptat de l&#8217;Organitzaci\u00f3 Mundial de la Salut (<a href=\"https:\/\/www.who.int\/news\/item\/01-09-2023-one-in-three-men-worldwide-are-infected-with-genital-human-papillomavirus\">enlla\u00e7<\/a>)<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><em>L\u2019Institut d&#8217;Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) \u00e9s un centre de recerca en biomedicina creat l\u2019any 2004. Est\u00e0 participat per l&#8217;Hospital Universitari de Bellvitge i l\u2019Hospital de Viladecans de l&#8217;Institut Catal\u00e0 de la Salut, l&#8217;Institut Catal\u00e0 d&#8217;Oncologia, la Universitat de Barcelona i l\u2019Ajuntament de l\u2019Hospitalet de Llobregat.<\/em><\/p>\n<p><em>L\u2019IDIBELL \u00e9s membre del Campus d&#8217;Excel\u00b7l\u00e8ncia Internacional de la Universitat de Barcelona HUBc i forma part de la instituci\u00f3 CERCA de la Generalitat de Catalunya. L&#8217;any 2009 es va convertir en un dels cinc primers centres d\u2019investigaci\u00f3 espanyols acreditats com a institut d\u2019investigaci\u00f3 sanit\u00e0ria per l\u2019Instituto de Salud Carlos III. A m\u00e9s, forma part del programa \u201cHR Excellence in Research\u201d de la Uni\u00f3 Europea i \u00e9s membre de EATRIS i REGIC. Des de l\u2019any 2018, l\u2019IDIBELL \u00e9s un Centro Acreditado de la Fundaci\u00f3n Cient\u00edfica AECC (FCAECC).<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>1 de cada 3 homes de 15 anys o m\u00e9s est\u00e0 infectat amb almenys un tipus de virus del papil\u00b7loma hum\u00e0 genital (VPH) i 1 de cada 5 est\u00e0 infectat amb un o m\u00e9s dels que s\u00f3n coneguts com d&#8217;alt risc o oncog\u00e8nics<\/p>\n","protected":false},"author":8,"featured_media":24201,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"categories":[332,337,454],"tags":[],"publishpress_future_action":{"enabled":false,"date":"2024-05-16 22:42:44","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/24200"}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=24200"}],"version-history":[{"count":1,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/24200\/revisions"}],"predecessor-version":[{"id":24202,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/24200\/revisions\/24202"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/24201"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=24200"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=24200"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=24200"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}